RaQualia Pharma Inc.
4579.T · JPX
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | ¥8 | ¥15 | ¥26 | ¥25 |
| - Cash | ¥3 | ¥4 | ¥4 | ¥2 |
| + Debt | ¥3 | ¥0 | ¥0 | ¥0 |
| Enterprise Value | ¥9 | ¥12 | ¥22 | ¥22 |
| Revenue | ¥3 | ¥2 | ¥3 | ¥3 |
| % Growth | 63.5% | -34.8% | 5.1% | – |
| Gross Profit | ¥2 | ¥2 | ¥3 | ¥2 |
| % Margin | 79.9% | 87.1% | 92.1% | 88.4% |
| EBITDA | ¥0 | -¥0 | ¥1 | ¥1 |
| % Margin | 6.1% | -5.9% | 34.4% | 36.9% |
| Net Income | -¥0 | -¥0 | ¥1 | ¥1 |
| % Margin | -15.9% | -17% | 24.8% | 27.2% |
| EPS Diluted | -22.87 | -14.98 | 34.47 | 36.04 |
| % Growth | -52.7% | -143.5% | -4.4% | – |
| Operating Cash Flow | ¥0 | -¥1 | ¥1 | ¥0 |
| Capital Expenditures | -¥0 | -¥0 | -¥0 | -¥0 |
| Free Cash Flow | ¥0 | -¥1 | ¥1 | ¥0 |